'Quality of CI more important than price'

Skandia’s survey of nearly 500 advisers suggests advisers feel clients are better off buying a quality critical illness (CI) product rather than a cheaper policy which covers a reduced number of illness or has fewer additional benefits. Advisers believe the range of illness covered is the most important aspect of CI policies, with 60% rating it as ‘very important’, followed by the inclusion of additional benefits such as low-grade cancer cover at 57%. Price was rated as the third most important aspect for advisers, with 44% saying it was very important. Skandia says the figures cast s...